Ami, Japan

Mitsunobu Shimazu


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Ibaraki, JP (1992)
  • Ami, JP (1990 - 1993)

Company Filing History:


Years Active: 1990-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsunobu Shimazu: Innovator in Microbial Biotechnology

Introduction

Mitsunobu Shimazu is a notable inventor based in Ami, Japan, recognized for his contributions to microbial biotechnology. He holds three patents that focus on innovative methods for treating microorganism cells and producing essential amino acids. His work has significant implications for industrial applications, particularly in the production of L-threonine.

Latest Patents

Shimazu's latest patents include a method of treating microorganism cells containing tryptophanase, which involves heat-treating these cells in the presence of an ammonium ion. This method selectively inhibits pyruvic acid decomposition activity, enhancing the efficiency of microbial processes. Another significant patent details a method for producing L-threonine, which utilizes enzymatic reactions involving L- or DL-aspartic acid in the presence of a biotin-requiring microorganism. This innovative approach allows for high yields of L-threonine production without the need for cumbersome operations like medium sterilization, making it a cost-effective solution for industrial applications.

Career Highlights

Throughout his career, Shimazu has worked with prominent organizations, including the Research Association for Utilization of Light Oil and Mitsubishi Petrochemical Company Limited. His experience in these institutions has contributed to his expertise in microbial biotechnology and patent development.

Collaborations

Shimazu has collaborated with notable colleagues such as Hideaki Yukawa and Masato Terasawa, further enhancing his research and innovation in the field.

Conclusion

Mitsunobu Shimazu's work in microbial biotechnology and his innovative patents have made a significant impact on the industry. His methods for treating microorganism cells and producing L-threonine demonstrate his commitment to advancing biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…